Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the epidermal growth factor receptor (EGFR) has revolutionized the management of non-small-cell lung cancer (NSCLC). Because these drugs are commonly used in combination with other types of medication, the risk of clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zi-Yi, Li, Jun-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636179/
https://www.ncbi.nlm.nih.gov/pubmed/31371986
http://dx.doi.org/10.2147/OTT.S194870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636179/
https://www.ncbi.nlm.nih.gov/pubmed/31371986
http://dx.doi.org/10.2147/OTT.S194870

Ejemplares similares